Seth A. Rudnick
Fondatore presso Altesa Biosciences, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Arthur Kirsch | M | 72 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 20 anni |
| Stephen Bloch | M | 62 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 15 anni |
| Michael Kaseta | M | 48 | 8 anni | |
| Christy Shaffer | M | 66 |
Artizan Biosciences, Inc.
 Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | 7 anni |
| Joanna Horobin | M | 69 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 anni |
| Damian deGoa | M | 45 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 anni |
| Katherine Rielly-Gauvin | F | 61 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 anni |
| Jack Bailey | M | 59 | 4 anni | |
| Raman Singh | M | 53 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 anni |
| Garry Nicholson | M | 69 | 6 anni | |
| John Clerici | M | 54 |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | - |
| Lloyd Kramer | M | - |
The University of North Carolina at Chapel Hill
| - |
| Roger Jeffs | M | 62 | 4 anni | |
| Brett P. Giroir | M | - |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | - |
| Norman Sharpless | M | 57 |
The University of North Carolina at Charlotte
| 8 anni |
| Ofira Kadmor | F | - |
Pitango Venture Capital
 Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 8 anni |
| Terry Murdock | M | 64 | 7 anni | |
| Habib Hazzan | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 31 anni |
| Tushar Shah | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 anni |
| Douglas Dibbert | M | - |
The University of North Carolina at Chapel Hill
| - |
| Charles Duckett | M | - |
The University of North Carolina at Chapel Hill
| - |
| Steven Bariahtaris | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 anni |
| David Suh | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 8 anni |
| Bridget Martell | M | 58 |
Artizan Biosciences, Inc.
Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | 3 anni |
| E. Jonathan Soderstrom | M | 69 |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.
Artizan Biosciences, Inc.
Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | 28 anni |
| Kevin Rakin | M | 63 |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | 3 anni |
| Alicia Secor | F | 62 | 3 anni | |
| Glenn Muir | M | 65 | 9 anni | |
| Chemi Peres | M | 64 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 28 anni |
| Rami Kalish | M | 67 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 31 anni |
| Zeev Binman | M | 70 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 26 anni |
| Paul Manning | M | 68 | 4 anni | |
| William C. Roberts | M | 54 | 3 anni | |
| Ittai Harel | M | 56 |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir.
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 18 anni |
| Cynthia Flowers | F | 64 | 6 anni | |
| Eyal Klein | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 1 anni |
| Robert Lippe | M | 59 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 9 anni |
| Gustavo Oliveira | M | - |
The University of North Carolina at Chapel Hill
| - |
| Susan Prevette | F | - |
The University of North Carolina at Chapel Hill
| - |
| Tamara Bickston | F | - |
The University of North Carolina at Chapel Hill
| - |
| Maxine Brown-Davis | F | - |
The University of North Carolina at Chapel Hill
| - |
| Martin Godwin | M | - |
The University of North Carolina at Chapel Hill
| - |
| Peter Tawil | M | - |
The University of North Carolina at Chapel Hill
| - |
| Zachary Howell | M | - |
The University of North Carolina at Chapel Hill
| - |
| Philip McAlpin | M | - |
The University of North Carolina at Chapel Hill
| - |
| Suzanne Pecheles | F | - |
The University of North Carolina at Chapel Hill
| - |
| Sarah Geer | F | - |
The University of North Carolina at Chapel Hill
| - |
| Joshua Kmiec | M | - |
The University of North Carolina at Chapel Hill
| - |
| Dave Maldonado | M | - |
The University of North Carolina at Chapel Hill
| - |
| Jim Leloudis | M | - |
The University of North Carolina at Chapel Hill
| - |
| Michael Surles | M | - |
The University of North Carolina at Chapel Hill
| - |
| Gary Lucci | M | - |
The University of North Carolina at Chapel Hill
| - |
| Priscilla Maynor | F | - |
The University of North Carolina at Chapel Hill
| - |
| Kristen McGuinness | F | - |
The University of North Carolina at Chapel Hill
| - |
| Garrett Strickland | M | - |
The University of North Carolina at Chapel Hill
| - |
| Denise St. Jean | F | - |
The University of North Carolina at Chapel Hill
| - |
| Jonathan Glazer | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 2 anni |
| Rachelle Feldman | F | - |
The University of North Carolina at Chapel Hill
| - |
| Ricardo Padilla | M | - |
The University of North Carolina at Chapel Hill
| - |
| Carol Haggerty | F | - |
The University of North Carolina at Chapel Hill
| - |
| Chris Weathington | M | - |
The University of North Carolina at Chapel Hill
| - |
| Margaret Diab | F | - |
The University of North Carolina at Chapel Hill
| - |
| Darlene Gooch | F | - |
The University of North Carolina at Chapel Hill
| - |
| Susan Bridgers | F | - |
The University of North Carolina at Chapel Hill
| - |
| Henry Foreman | M | - |
The University of North Carolina at Chapel Hill
| - |
| Alex Idichandy | M | - |
The University of North Carolina at Chapel Hill
| - |
| Kevin Guskiewicz | M | - |
The University of North Carolina at Chapel Hill
| - |
| Andrew Whittemore | M | - |
The University of North Carolina at Chapel Hill
| - |
| Justin Haslett | M | - |
The University of North Carolina at Chapel Hill
| - |
| Wolfgang Bergmeier | M | - |
The University of North Carolina at Chapel Hill
| - |
| Jacqueline Wynn | F | - |
The University of North Carolina at Chapel Hill
| - |
| Donald Haggis | M | - |
The University of North Carolina at Chapel Hill
| - |
| Brian Kuhlman | M | - |
The University of North Carolina at Chapel Hill
| - |
| Paul Dayton | M | - |
The University of North Carolina at Chapel Hill
| - |
| Max Owre | M | - |
The University of North Carolina at Chapel Hill
| - |
| Jane Monaco | F | - |
The University of North Carolina at Chapel Hill
| - |
| Allen Samuelson | M | - |
The University of North Carolina at Chapel Hill
| - |
| Dean Morrell | M | - |
The University of North Carolina at Chapel Hill
| - |
| Jay Brenman | M | - |
The University of North Carolina at Chapel Hill
| - |
| Todd Austell | M | - |
The University of North Carolina at Chapel Hill
| - |
| Nita Eskew | F | - |
The University of North Carolina at Chapel Hill
| - |
| Molly Berkoff | F | - |
The University of North Carolina at Chapel Hill
| - |
| Jenny Tone-Pah-Hote | F | - |
The University of North Carolina at Chapel Hill
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Neal Fowler | M | 62 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 9 anni |
| Eric Trachtenberg | M | 51 | 3 anni | |
| Jay C. Strum | M | - | 11 anni | |
| Jennifer Lou Armstrong-Owen | F | 54 | 4 anni | |
| John R. Plachetka | M | 70 | 19 anni | |
| Adrian Adams | M | 73 | 4 anni | |
| Mark Velleca | M | 60 | 9 anni | |
| Matthew Zuga | M | 58 |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY. | 1 anni |
| D. Alan Quarterman | M | - |
University of Virginia
| 8 anni |
| Ralph Snyderman | M | 84 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Scott J. Charles | M | 49 | 2 anni | |
| Robert S. Muehlenbeck | M | 75 | 10 anni | |
| Susan G. Casey | F | 64 | 11 anni | |
| Douglas H. Bowers | M | 66 | 4 anni | |
| Jennifer Moses | F | 49 | - | |
| James Beitchman | M | - |
University of Virginia
University of Pennsylvania
| 11 anni |
| James L. Vincent | M | 84 | 12 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
| Canada | 7 | 7.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Seth A. Rudnick
- Contatti personali